Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release. (scientific article published on 25 April 2008)

Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate

Q48501061

Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands

Q52052247

Inhibition and dissociation of [3H]-paroxetine binding to human platelets

Q69320679

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Q28143430

Therapeutic potential of monoamine transporter substrates

Q28266724

SSRIs and SNRIs: broad spectrum of efficacy beyond major depression

Q33543679

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

Q34053653

In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates

Q34227794

Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1.

Q34469567

G protein-coupled receptor allosterism and complexing

Q34523552

Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act?

Q34581080

Binding surface analysis: an intuitive yet quantitative method for the design and analysis of ligand binding studies

Q39501827

Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter

Q40429339

Characterization of an allosteric citalopram-binding site at the serotonin transporter.

Q40479596

From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters

Q40713073

Nongenomic steroidal modulation of high-affinity serotonin transport

Q40967286

Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding

Q42164303

3H cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine

Q43710268

Salvinorin A: allosteric interactions at the mu-opioid receptor

Q44332543

Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter

Q44965402

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

286-295

P577

publication date

2008-04-25

P1433

published in

Journal of Pharmacology and Experimental Therapeutics

Q1500272

P1476

title

Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release

P478

volume

326

Reverse relations

cites work (P2860)

Q33808035	Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.
Q36248541	Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters
Q38098582	Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices
Q37196323	HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes
Q37672037	HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
Q64054571	Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport
Q26853319	Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates
Q36912735	Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity.
Q34467830	Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency
Q24655326	Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine release
Q34249270	Studies of the biogenic amine transporters. 14. Identification of low-efficacy "partial" substrates for the biogenic amine transporters
Q41922188	The role of human dopamine transporter in NeuroAIDS.